Product and geographic diversity; Competitive market and constant pricing pressures; Products range from mid-to-lower end of the technology scale compared with leading medical device peers; and Average EBITDA margins, compared with those of its medical device company peers. Expectations of steady revenue growth and EBITDA margins; Financial metrics on the stronger end of its financial risk profile descriptor; Solid internal cash flow generation; and Adequate liquidity. S&P Global Ratings' stable outlook on Wayne, Pa.-based Teleflex Inc. reflects the expectation that modest organic revenue growth, stable operating margins, and strong free cash flow generation will result in Teleflex maintaining adjusted debt leverage between 2x and 3x over the next two years. We could lower the rating if operating performance meaningfully falls
